Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOISS Study: Botulinum toxin type A for spasmodic dysphonia
jRCT2091220176Phase 3Completed
- Sponsor
- Kochi University Hospital Department of Otolaryngology
- Start
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in laryngeal dystonia (SD) comparing Botulinum toxin type A with Placebo (2 arms). Primary endpoint: Change in number of moras. Started Apr 2014; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
laryngeal dystonia (SD)
Beyond the preview
Go deeper on jRCT2091220176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220176.